Exchange: NYSE·Updated 07:30 PM EST

ZBH News

News
all
press releases
Zimmer Biomet Eyes Faster Growth in 2027, Targets Earlier Robotics Launch
Zimmer Biomet (NYSE:ZBH) expects revenue growth to improve in 2027 after exceeding its own expectations in each of the first three quarters of 2026, CEO Ivan Tornos said during a Jefferies fireside chat. Tornos pointed to a diminishing headwind in China, progress in the company's U.S. sales force t...
MarketBeat
Zimmer Biomet Eyes Faster Growth in 2027, Targets Earlier Robotics Launch
Zimmer Biomet (NYSE:ZBH) expects revenue growth to improve in 2027 after exceeding its own expectations in each of the first three quarters of 2026, CEO Ivan Tornos said during a Jefferies fireside chat. Tornos pointed to a diminishing headwind in China, progress in the company's U.S. sales force t...
MarketBeat
More News
Wells Fargo & Company upgraded Zimmer Biomet from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $113.00 to $123.00 in a research note on Tuesday...
MarketBeat
BMO Capital Markets reduced their price objective on Zimmer Biomet from $102.00 to $101.00 and set a "market perform" rating on the stock in a research note on Monday...
MarketBeat
Aberdeen Group plc lifted its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 329.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 620,546 shares of the medical equipment provider's stoc...
MarketBeat
Alberta Investment Management Corp grew its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 84.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 550,000 shares of the medical equipment pro...
MarketBeat
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
ZBH beats Q3 earnings and revenue estimates, lifting its 2026 outlook as strong Hips and S.E.T. sales offset weakness in Knees amid margin pressure.
Zacks
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
(RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) will host a conference call at 8:30 AM ET on November 4, 2026, to discuss Q3 26 earnings results...
Nasdaq News: Markets
(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, on Wednesday reported lower profit for the third quarter, compared with the prior year quarter. Further, the firm raised its full year earnings per share and revenue outlook...
Nasdaq News: Markets

Advertisement|Remove ads.